unknown
Stage
About
Verigraft develops personalized tissue-engineered vein therapies to treat chronic venous insufficiency using donated human tissue combined with the patient's own blood to restore vein function and reduce rejection risk.
Explore Verigraft's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.